Isogenic H/N/KRAS-less mouse embryonic fibroblast (MEF) cell lines have been developed to assist in cell-based assays of RAS inhibitors. The quality control assessment of a panel of these isogenic MEFs is described here, with a focus on ensuring the proper insertion of the desired mutant RAS transgene, a determination of gene copy number, and an investigation of potential off-target mutations which could lead to phenotypes which are undesired in downstream experiments. Using this suite of quality control tools, a MEF cell line can be readily validated, and researchers can be assured of the rationale for an observed phenotype.
Keywords: Capillary electrophoresis; Copy number analysis; Droplet digital PCR (ddPCR); Next-generation sequencing (NGS) analysis; Sanger sequencing; Transgene; Vector integration site assay (VISA); Whole exome sequencing (WES).
© 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.